Head-to-head · WeighScore
Bliv vs Enara Health
The verdict
Bliv takes it — 66.3/100 to 65.3/100, but only just.
Bliv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bliv is a telehealth provider selling personalised compounded GLP-1 programmes. Enara Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bliv | Enara Health |
|---|---|---|
| WeighScore | 66.3/100 | 65.3/100 |
| Grade | C | C |
| Scorecard rank | #187 | #221 |
| Semaglutide | $116/mo (as low as, varies by plan and eligibility, compounded) | Not disclosed |
| Tirzepatide | $199/mo (as low as, varies by plan and eligibility, compounded) | Not disclosed |
| Coverage | Coverage not published | 6 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #187 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
- A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
- The homepage advertises 'no long-term commitments or cancellation fees' while the terms require the membership fee to be paid 'in a single sum', call it non-refundable and refer to a 'Membership Term'
- The only figure smaller than the advertised rate is a $29 CareCredit/Klarna instalment, which is a financing payment rather than the price of a month of medication
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #221 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
- Insurance-based with prior-auth coverage for over 65% of members
- Board-certified obesity-medicine physicians
- Comprehensive program: dietitian, coaching, metabolic and genetic testing
- Established since 2015 with clinical track record
Where it loses points
- Available in only six states via partner clinics
- Requires in-network insurance; not a flat cash-pay option
- Not a pure-telehealth nationwide service
- Out-of-pocket cost varies by insurance coverage
- No compounded budget alternative for the uninsured
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.